Equities analysts expect Alcentra Capital Corp (NASDAQ:ABDC) to announce sales of $8.15 million for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Alcentra Capital’s earnings, with the lowest sales estimate coming in at $7.92 million and the highest estimate coming in at $8.37 million. Alcentra Capital posted sales of $9.20 million during the same quarter last year, which would indicate a negative year-over-year growth rate of 11.4%. The business is expected to announce its next earnings report on Thursday, May 3rd.
According to Zacks, analysts expect that Alcentra Capital will report full-year sales of $8.15 million for the current fiscal year, with estimates ranging from $31.06 million to $34.45 million. For the next fiscal year, analysts anticipate that the business will report sales of $33.85 million per share. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that follow Alcentra Capital.
Several analysts recently issued reports on the stock. Keefe, Bruyette & Woods set a $7.00 price target on shares of Alcentra Capital and gave the company a “hold” rating in a report on Thursday. ValuEngine cut shares of Alcentra Capital from a “buy” rating to a “hold” rating in a report on Thursday. Raymond James Financial upgraded shares of Alcentra Capital from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 11th. Finally, UBS upgraded shares of Alcentra Capital from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 11th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. Alcentra Capital has an average rating of “Hold” and a consensus price target of $12.00.
A number of hedge funds have recently added to or reduced their stakes in ABDC. Goldman Sachs Group Inc. bought a new stake in Alcentra Capital during the second quarter valued at $219,000. Royal Bank of Canada increased its stake in Alcentra Capital by 1,948.4% during the second quarter. Royal Bank of Canada now owns 8,808 shares of the asset manager’s stock valued at $120,000 after purchasing an additional 8,378 shares during the last quarter. Commerce Bank bought a new stake in Alcentra Capital during the third quarter valued at $159,000. Spectrum Management Group Inc. bought a new stake in Alcentra Capital during the third quarter valued at $107,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in Alcentra Capital during the third quarter valued at $123,000. Hedge funds and other institutional investors own 35.01% of the company’s stock.
Alcentra Capital stock traded down $0.10 on Friday, reaching $6.12. 89,541 shares of the company traded hands, compared to its average volume of 79,823. The firm has a market capitalization of $88.36, a PE ratio of 4.71 and a beta of 0.55. Alcentra Capital has a 1 year low of $6.10 and a 1 year high of $14.73.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 4th. Shareholders of record on Friday, March 30th will be paid a dividend of $0.18 per share. The ex-dividend date is Wednesday, March 28th. This represents a $0.72 annualized dividend and a yield of 11.76%. Alcentra Capital’s payout ratio is -74.07%.
ILLEGAL ACTIVITY WARNING: “Alcentra Capital Corp (ABDC) Expected to Post Quarterly Sales of $8.15 Million” was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.thelincolnianonline.com/2018/04/11/alcentra-capital-corp-abdc-expected-to-post-quarterly-sales-of-8-15-million.html.
About Alcentra Capital
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.